Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study

Area of Science:

• Ophthalmology
• Microbiology
• Materials Science

Background:

• Microbial contamination of eye drop containers is a significant concern, with contamination rates ranging from 7.7% to 100%.
• Preventing contamination is crucial for patient safety and requires innovative solutions.

Purpose of the Study:

• To compare the antimicrobial efficiency and practical use of standard eye drop packaging versus a novel container with integrated antimicrobial technology.
• To identify microbial contaminants present on commonly used eye drops.

Main Methods:

• A two-phase study was conducted: Phase 1 (in situ) identified microbial contaminants in hospital and community eye drops (n=110).
• Phase 2 (in vitro) assessed antimicrobial efficacy using JIS Z2801 standards on packaging with Pylote SAS antimicrobial technology.
• Practical usability tests were also performed.

Main Results:

• The most prevalent bacteria identified were *Staphylococcus* species. *Candida parapsilosis* was found in one sample and on its cap/tip.
• The Pylote SAS packaging demonstrated over a one-log reduction in *Staphylococcus aureus* and *Pseudomonas aeruginosa* counts after 24 hours.
• Practical tests confirmed satisfactory usability of the new packaging.

Conclusions:

• The Pylote SAS antimicrobial mineral oxide technology shows significant potential for reducing microbial contamination on eye drop container tips and caps.
• This technology offers a promising combination of effectiveness, safety, and sustainability for preventing eye drop-related infections.